Furthermore, LCL-461, a soluble C18-ceramide analog drug, accumulates in mitochondria and induces lethal mitophagy in AML cells expressing FLT3 mutations and in blasts obtained from FLT3-ITD1 AML patients [24]. The gene discussed is FLT3; the disease is acute myeloid leukemia.